Browse the site

Start with a goal 40 things people take supplements for — sleep, stress, joints, focus.
Home Get the app
Tetrahydrocannabinol

Tetrahydrocannabinol

Best for

Feel less pain

Large effect, needs confirmation 1.22–4.4 mg/day 8 weeks 2 meta-analyses, n=294 #8 of 50 studied

  • 10 papers
  • 5 of 23 outcomes
  • 3 positive

Tetrahydrocannabinol offers likely real but unnoticeable neuropathy symptom relief, while evidence across other outcomes does not support meaningful improvements in sleep or chemotherapy-related nausea.

Median effective dose, most-studied outcomes

  • Feel less intense pain 2.81 mg 8 wk
  • Ease neuropathic pain 28 mg —
Full protocol, 2 outcomes

What tetrahydrocannabinol actually does

Outcome Effect Evidence Dose Time Rank
Modest benefits 1
Ease neuropathy symptoms Likely real but unnoticeable Neuropathy can cause pain, numbness, tingling, weakness, and changes in sensation.
trivial 		1 meta-analysis 1 papers · n=2.5k — — #8 /12
Worth watching 2
Feel less pain Large effect, needs confirmation Pain relief can make it easier to move, rest, focus, and get through the day.
large 		2 meta-analyses 4 papers · n=294 1.22–4.4 mg 8 wk #8 /50
Ease neuropathic pain Large effect, needs confirmation Neuropathic pain comes from damaged or irritated nerves and can feel burning, shooting, or electric.
large 		1 RCT 1 papers · n=16 16–28 mg — #2 /5
Doesn't appear to help 2
Less nausea and vomiting with chemotherapy Probably doesn't help Nausea, vomiting, and appetite loss can make it hard to eat and drink during chemotherapy.
large 		1 meta-analysis 1 papers · n=1.0k — — —
Sleep that feels more restorative Probably doesn't help Sleep quality reflects whether the night leaves you feeling well rested.
trivial 		1 meta-analysis 1 papers · n=2.5k — — —

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

For general pain, small measured sublingual THC doses of 1.22 to 4.4 mg were studied over 8 weeks, with a median effective dose near 2.81 mg. 1 Nerve-pain research used substantially higher doses, 16 to 28 mg, but that finding comes from one early study and needs replication before it becomes a standard target. 2 Start only under guidance from a clinician familiar with cannabinoid products, since THC effects can become unpleasant well before a dose feels useful.

When and how long

Pain protocols used THC as a scheduled daily treatment over weeks, not as an occasional response to a bad day. 1 Sublingual products generally act faster than swallowed products, while oral doses have a slower and less predictable onset, so changing routes can change both the experience and the dose that feels tolerable. 1 Avoid driving, alcohol, and tasks that require quick reactions after taking THC.

Forms & standardisation

The most informative pain evidence comes from measured, labeled cannabinoid medicines and sublingual preparations, not from smoked cannabis or loosely dosed edibles. 1 Look for THC listed in milligrams per dose and a clear product type. Do not assume a product that also contains cannabidiol, often shortened to CBD, produces the same effects as THC alone, because combination products complicate the evidence. 1

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Feel less intense pain 1.22–4.4 mg 2.81 mg 8 wk 4 papers 2 sig. endpoints
Ease neuropathic pain 16–28 mg 28 mg — 1 paper 6 sig. endpoints
In context

What this is and how it works

  • One study (n=2,471) reported positive neuropathy symptom outcomes, but no numerical effect or noticeable-change threshold was provided.1
  • The review covered 10 papers spanning 23 outcomes, including chronic neuropathic pain, sleep, and chemotherapy-related nausea.
  • Evidence for neuropathy relief remains early, with findings varying by product, dose, and patient population.

Tetrahydrocannabinol, usually called THC, is the cannabis plant compound responsible for the familiar intoxicating high. It comes in measured pharmaceutical-style oils, sprays, capsules, and sublingual products, as well as less predictable consumer cannabis products. Research on pain often examines THC alongside other cannabis compounds, which makes product labels and exact doses especially important. 1 2

THC switches on cannabinoid type 1 receptors, the signal controls found on many nerve cells in the brain and spinal cord. Think of those receptors as a volume dial on an overactive alarm wire: activating them can turn down incoming pain messages before the brain interprets them as urgent. 1

Bottom line

THC is worth discussing with a clinician if pain, especially nerve-related pain, has not responded to simpler options and you can use a measured product cautiously. The pain signal is promising but still early, and the evidence does not support using THC for better restorative sleep or delayed chemotherapy nausea. 1 3 4 Avoid self-directed use if intoxication, impaired coordination, or anxiety-like reactions would create a meaningful safety risk.

Frequently asked

Common questions

Does THC help with pain?

Early trials show that THC-containing products can reduce pain intensity, including nerve-related pain, but the evidence base is small and products, doses, and routes differ widely. 1 2

Does THC improve sleep quality?

No. The reviewed sleep trial showed no meaningful improvement in restorative sleep, so THC is not a reliable sleep-quality supplement based on this evidence. 4

What is the best way to take THC for pain?

The pain studies used measured sublingual or oral products rather than guessing with smoked or edible cannabis. Route changes how quickly THC reaches the bloodstream and how long its effects last, so do not treat product formats as interchangeable. 1

Sources

Sources

  1. 1. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (2015) ↑
  2. 2. Cannabis-based medicines for chronic neuropathic pain in adults (2018) ↑
  3. 3. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy (2015) ↑
  4. 4. Cannabis, Cannabinoids, and Sleep: a Review of the Literature (2021) ↑

Generated August 27, 2026

Related

More evidence for Tetrahydrocannabinol